Minoxidil 5% Topical Solution

DRUG5 trials

Sponsors

Dermaliq Therapeutics, Inc., Indonesia University, PDFE Pharma Innovations FZCO, Shenzhen People's Hospital, Triple Hair Inc

Conditions

Alopecia, AndrogeneticAndrogenetic AlopeciaAndrogenetic Alopecia (AGA)Androgenic AlopeciaBaldness

Phase 1

Safety and Efficacy Study of Topical DLQ01 in the Treatment of Androgenetic Alopecia (AGA) in Men

CompletedNCT05636904

Dermaliq Therapeutics, Inc.Androgenetic Alopecia

Start: 2022-12-05End: 2024-03-28Updated: 2024-04-08

A Study on the Treatment of Androgenetic Alopecia in Young Men With Umbilical Cord Mesenchymal Stem Cell Exosomes

RecruitingNCT07203599

Shenzhen People's HospitalAndrogenic Alopecia

Start: 2025-09-20End: 2026-11-01Target: 59Updated: 2025-12-02

Phase 2

A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.

Active, not recruitingNCT07011485

PDFE Pharma Innovations FZCOAlopecia, Androgenetic, Androgenetic Alopecia (AGA), Baldness

Start: 2025-05-14End: 2025-09-17Target: 15Updated: 2025-06-08

Phase 3

Effectiveness of Combination Therapy of Microneedling and Minoxidil in Androgenetic Alopecia of Indonesian Men

CompletedNCT05989165

Indonesia UniversityAndrogenetic Alopecia

Start: 2023-06-01End: 2023-09-15Updated: 2023-09-28

Androgenic Alopecia TH07 Clinical Trial

RecruitingNCT07435012

Triple Hair IncAndrogenic Alopecia

Start: 2026-04-01End: 2028-04-01Target: 420Updated: 2026-03-16